Nasdaq Jumps 150 Points; US Pending Home Sales Rise - Kala Bio (NASDAQ:KALA), IO Biotech (NASDAQ:IOBT)

Market Overview - U.S. stocks traded higher, with the Nasdaq Composite gaining around 150 points on Monday, while the Dow rose 0.19% to 46,333.68, the NASDAQ increased 0.67% to 22,635.76, and the S&P 500 climbed 0.42% to 6,671.51 [1] - Information technology shares jumped by 0.8%, while energy stocks fell by 0.8% [1] Real Estate Sector - U.S. pending home sales surged by 4% in August, marking the sharpest gain in five months, compared to a 0.4% decline in the previous month [2][7] Commodity Market - Oil traded down 2% to $64.41, while gold increased by 0.9% to $3,844.30. Silver rose 0.5% to $46.895, and copper gained 0.7% to $4.8070 [4] European Market - European shares were mostly higher, with the eurozone's STOXX 600 gaining 0.2%, while Spain's IBEX 35 Index fell 0.2%. London's FTSE 100 rose 0.4%, Germany's DAX 40 slipped 0.1%, and France's CAC 40 climbed 0.3% [5] Asian Market - Asian markets closed mixed, with Japan's Nikkei 225 falling 0.69%, Hong Kong's Hang Seng gaining 1.89%, China's Shanghai Composite rising 0.90%, and India's BSE Sensex falling 0.08% [6] Stock Performance - Maison Solutions Inc. (NASDAQ: MSS) shares surged 257% to $3.3603, while Predictive Oncology Inc. (NASDAQ: POAI) increased 112% to $1.64 after announcing a 1-for-15 reverse stock split. Maison Solutions Inc. also saw a 167% gain to $2.56 [9] - KALA BIO, Inc. (NASDAQ: KALA) shares dropped 92% to $1.4350 after failing to meet primary endpoints in a clinical trial. MoonLake Immunotherapeutics (NASDAQ: MLTX) shares fell 89% to $6.76 following disappointing trial results, and IO Biotech, Inc. (NASDAQ: IOBT) was down 75% to $0.3941 after an update post-FDA meeting [9]